203453-41-2

Upstream product

• 203455-56-5 (1-(benzothiazol-2-yl-hydroxy-methyl)-4-{[tert-butoxycarbonylimino-(4-methoxy-2,3,6-trimethyl-benzenesulfonylamino)-methyl]-amino}-butyl)-carbamic acid tert-butyl ester 
• 203453-39-8 N-<4-amino-5-(1,3-benzothiazol-2-yl)-5-hydroxypentyl>-N'-<(4-methoxy-2,3,6-trimethylphenyl)sulfonyl>guanidine 
• 183442-72-0 4-<(tert-butoxycarbonyl)amino>-4-benzyltetrahydropyridazin-3(2H)-one 
• 183442-71-9 4-<(tert-butoxycarbonyl)amino>-4-benzyldihydropyridazin-3(2H)-one 
• 183442-69-5 methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]pent-4-enoate 
• 183442-70-8 methyl l-2-<(tert-butoxycarbonyl)amino>-4-oxobutanoate 
• 183442-80-0 ((S)-4-{[[(Z)-tert-Butoxycarbonylimino]-(4-methoxy-2,3,6-trimethyl-benzenesulfonylamino)-methyl]-amino}-1-formyl-butyl)-carbamic acid tert-butyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 95-16-9 1,3-Benzothiazole 
• 203518-05-2 C₄₃H₅₆N₈O₈S₂ 

Relevant academic research and scientific papers

Secondary structure peptide mimetics: Design, synthesis, and evaluation of β-strand mimetic thrombin inhibitors

Constrained dipeptide mimetic templates were designed to mimic the secondary structure of peptides in a β-strand conformation. Two templates corresponding to the D-Phe-Pro portion of the thrombin inhibitor D-Phe-Pro- ArgCH2Cl were synthesized a